US Stock MarketDetailed Quotes

ZTS Zoetis

Watchlist
  • 157.520
  • -7.410-4.49%
Close Feb 14 16:00 ET
  • 158.020
  • +0.500+0.32%
Post 20:01 ET
70.54BMarket Cap28.80P/E (TTM)

About Zoetis Company

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.

Company Profile

SymbolZTS
Company NameZoetis
Listing DateFeb 1, 2013
Issue Price26.00
Founded1952
CEOMs. Kristin C. Peck
MarketNYSE
Employees14100
Fiscal Year Ends12-31
Address10 Sylvan Way
CityParsippany
ProvinceNew Jersey
CountryUnited States of America
Zip Code07054
Phone1-973-822-7000
Websitehttp://www.zoetis.com

Company Executives

  • Name
  • Position
  • Salary
  • Kristin C. Peck
  • Director and Chief Executive Officer
  • 15.24M
  • Julie Fuller
  • Executive Vice President, Global Operations and Chief Human Resources Officer
  • --
  • Jeannette Ferran Astorga
  • Executive Vice President, Corporate Affairs, Communications and Chief Sustainability Officer
  • --
  • Wetteny Joseph
  • Executive Vice President, Principal Accounting Officer and Chief Financial Officer
  • 4.25M
  • Keith Sarbaugh
  • Executive Vice President, Chief Digital Officer and Chief Technology Officer
  • --
  • Roxanne Lagano
  • Chief Human Resources Officer, Executive Vice President, Global Operations and Interim General Counsel and Corporate Secretary
  • --
  • Jamie Brannan
  • Executive Vice President and Chief Commercial Officer
  • --
  • Nick Ashton
  • Executive Vice President and President, Global Manufacturing and Supply
  • --
  • Rimma Driscoll
  • Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
  • --
  • Dr. Robert J. Polzer, PhD
  • Executive Vice President and President, Research and Development
  • 2.44M
  • Michael B. McCallister
  • Non-Executive Chairman of the Board
  • 490.00K
  • Jared Shriver
  • President, U.S. Operations
  • --
  • Gavin D.K. Hattersley
  • Director
  • --
  • Vanessa Broadhurst
  • Independent Director
  • 341.00K
  • Robert W. Scully
  • Independent Director
  • 365.00K
  • Frank A. D'Amelio
  • Independent Director
  • 340.50K
  • Antoinette R. Leatherberry
  • Independent Director
  • 340.00K
  • Gregory Norden
  • Independent Director
  • 365.00K
  • Dr. Willie M. Reed
  • Independent Director
  • 370.00K
  • Louise M. Parent
  • Independent Director
  • 370.00K
  • Sanjay Khosla
  • Independent Director
  • 340.00K
  • Paul M. Bisaro
  • Independent Director
  • 340.00K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025